Jonathan David Schwartz, See Remarks at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 11,161 shares at $3.02 ($34K) on 2025-08-14, disclosed to the SEC on 2025-08-18.
Open-market sale of $34k RCKT by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RCKT | SELL | 2025-05-22 | $5K | — | Filing → |
| RCKT | SELL | 2025-05-20 | $10K | — | Filing → |
| RCKT | SELL | 2025-02-27 | $357K | — | Filing → |